Trans American Aquaculture (GRPS) Change in Receivables (2023 - 2025)
Trans American Aquaculture (GRPS) reported Change in Receivables of -$12794.0 for Q2 2025, up 48.15% on a YoY basis from -$8636.1 in Q2 2024, and down 190.59% quarter-over-quarter from $14123.0 in Q4 2024.
Trans American Aquaculture (GRPS) Change in Receivables (2023 - 2025) Analysis & Trends
Trans American Aquaculture has reported Change in Receivables for 3 years, with the latest figure at -$12794.0 in Q2 2025.
- For the quarter ending Q2 2025, Change in Receivables rose 48.15% year-over-year to -$12794.0; the trailing twelve-month figure through Sep 2025 stood at $1329.0 (up 102.9% YoY), and the FY2024 full-year result was $26480.0, up 157.52% from the prior year.
- Change in Receivables for Q2 2025 stood at -$12794.0, down from $14123.0 in the prior quarter.
- The five-year high for Change in Receivables was $55199.0 in Q1 2024, with the low at -$58257.0 in Q4 2023.
- Historically, Change in Receivables has averaged -$3594.7 across 3 years, with a median of $3858.0 in 2023.
- The largest YoY upside for Change in Receivables was 1330.77% in 2024 against a maximum downside of 690.26% in 2024.
- Trans American Aquaculture's Change in Receivables stood at -$58257.0 in 2023, then surged by 124.24% to $14123.0 in 2024, then slumped by 190.59% to -$12794.0 in 2025.
- The last three Change in Receivables figures came in at -$12794.0 (Q2 2025), $14123.0 (Q4 2024), and -$18169.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -78.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 106.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -38.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 81.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 23.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 116.25 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.23 Mn |
| 10 | Trans American Aquaculture | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -12,794.00 |
| Jun 30, 2025 | -12,794.00 |
| Dec 31, 2024 | 14,123.00 |
| Dec 31, 2024 | 14,123.00 |
| Sep 30, 2024 | -18,169.00 |
| Sep 30, 2024 | -18,169.00 |
| Jun 30, 2024 | -24,673.00 |
| Jun 30, 2024 | -24,673.00 |
| Mar 31, 2024 | 55,199.00 |
| Mar 31, 2024 | 55,199.00 |
| Dec 31, 2023 | -58,257.00 |
| Dec 31, 2023 | -58,257.00 |
| Sep 30, 2023 | 4,181.00 |
| Sep 30, 2023 | 4,181.00 |
| Jun 30, 2023 | 4,180.00 |
| Jun 30, 2023 | 4,180.00 |
| Mar 31, 2023 | 3,858.00 |
| Mar 31, 2023 | 3,858.00 |